Company facts
- Headquarters
- Switzerland
About
Gene therapy is changing the future of medicine, receiving the first FDA approval for eye disease in 2017. Adeno-associated virus (AAV) is the most efficient vector for delivering genes to the eye. However, it displays relevant drawbacks/limits that may render the treatment ineffective. EVIS Bioscience developed a next…